Tian Yang, Ph.D.

Vice President, Preclinical Development

Tian Yang, Ph.D., is a Vice President, Preclinical Development, Deerfield Discovery and Development, and joined the Firm in 2022. Prior to Deerfield, Dr. Yang spent ten years at the Global Alliance for TB Drug Development with responsibility for toxicology, as well as drug metabolism and pharmacokinetics (DMPK). Before TB Alliance, he worked as Head of Enzymology and Drug Metabolism at Hoffmann-La Roche, and held various other roles at Bristol Myers Squibb and Dupont Pharmaceutical. He began his career at the National Cancer Institute, researching carcinogen-activating P450s. Dr. Yang holds a B.S. in Pharmacy from Lanzhou University, and a Ph.D. in Pharmacology and Toxicology from Peking Union Medical College. Dr. Yang is a Diplomate of the America Board of Toxicology (DABT).